Cargando…

Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019

BACKGROUND: Information about global and local epidemiology and trends of skin cancers is limited, which increases the difficulty of cutaneous cancer control. METHODS: To estimate the global spatial patterns and temporal trends of skin cancer burden. Based on the GBD 2019, we collected and analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Zeng, Wen, Jiang, Aofei, He, Zhi, Shen, Xiaoping, Dong, Xian, Feng, Jianglong, Lu, Hongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290243/
https://www.ncbi.nlm.nih.gov/pubmed/34105887
http://dx.doi.org/10.1002/cam4.4046
_version_ 1783724456751923200
author Zhang, Wei
Zeng, Wen
Jiang, Aofei
He, Zhi
Shen, Xiaoping
Dong, Xian
Feng, Jianglong
Lu, Hongguang
author_facet Zhang, Wei
Zeng, Wen
Jiang, Aofei
He, Zhi
Shen, Xiaoping
Dong, Xian
Feng, Jianglong
Lu, Hongguang
author_sort Zhang, Wei
collection PubMed
description BACKGROUND: Information about global and local epidemiology and trends of skin cancers is limited, which increases the difficulty of cutaneous cancer control. METHODS: To estimate the global spatial patterns and temporal trends of skin cancer burden. Based on the GBD 2019, we collected and analyzed numbers and age‐standardized rates (ASR) of skin cancer incidence, disability‐adjusted life years (DALYs) and mortality (ASIR, ASDR, and ASMR) in 204 countries from 1990 through 2019 were estimated by age, sex, subtype (malignant skin melanoma [MSM], squamous‐cell carcinoma [SCC], and basal‐cell carcinoma [BCC]), Socio‐demographic Index (SDI), region, and country. Temporal trends in ASR were also analyzed using estimated annual percentage change. RESULTS: Globally, in 2019, there were 4.0 million BCC, 2.4 million SCC, and 0.3 million MSM. There were approximately 62.8 thousand deaths and 1.7 million DALYs due to MSM, and 56.1 thousand deaths and 1.2 million DALYs were attributed to SCC, respectively. The men had higher ASR of skin cancer burden than women. The age‐specific rates of global skin cancer burden were higher in the older adults, increasing trends observed from 55 years old. Geographically, the numbers and ASR of skin cancers varied greatly across countries, with the largest burden of ASIR in high SDI regions. However, an unexpected increase was observed in some regions from 1990 to 2019, such as East Asia, and Sub‐Saharan Africa. Although there was a slight decrease of the ASMR and ASDR, the global ASIR of MSM dramatically increased, 1990–2019. Also, there was a remarkable increase in ASR of BCC and SCC burden. CONCLUSIONS: Skin cancer remains a major global public health threat. Reducing morbidity and mortality strategies such as primary and secondary prevention should be reconsidered, especially in the most prevalent and unexpected increased regions, especially for those areas with the greatest proportions of their population over age 55.
format Online
Article
Text
id pubmed-8290243
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82902432021-07-21 Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019 Zhang, Wei Zeng, Wen Jiang, Aofei He, Zhi Shen, Xiaoping Dong, Xian Feng, Jianglong Lu, Hongguang Cancer Med Cancer Prevention BACKGROUND: Information about global and local epidemiology and trends of skin cancers is limited, which increases the difficulty of cutaneous cancer control. METHODS: To estimate the global spatial patterns and temporal trends of skin cancer burden. Based on the GBD 2019, we collected and analyzed numbers and age‐standardized rates (ASR) of skin cancer incidence, disability‐adjusted life years (DALYs) and mortality (ASIR, ASDR, and ASMR) in 204 countries from 1990 through 2019 were estimated by age, sex, subtype (malignant skin melanoma [MSM], squamous‐cell carcinoma [SCC], and basal‐cell carcinoma [BCC]), Socio‐demographic Index (SDI), region, and country. Temporal trends in ASR were also analyzed using estimated annual percentage change. RESULTS: Globally, in 2019, there were 4.0 million BCC, 2.4 million SCC, and 0.3 million MSM. There were approximately 62.8 thousand deaths and 1.7 million DALYs due to MSM, and 56.1 thousand deaths and 1.2 million DALYs were attributed to SCC, respectively. The men had higher ASR of skin cancer burden than women. The age‐specific rates of global skin cancer burden were higher in the older adults, increasing trends observed from 55 years old. Geographically, the numbers and ASR of skin cancers varied greatly across countries, with the largest burden of ASIR in high SDI regions. However, an unexpected increase was observed in some regions from 1990 to 2019, such as East Asia, and Sub‐Saharan Africa. Although there was a slight decrease of the ASMR and ASDR, the global ASIR of MSM dramatically increased, 1990–2019. Also, there was a remarkable increase in ASR of BCC and SCC burden. CONCLUSIONS: Skin cancer remains a major global public health threat. Reducing morbidity and mortality strategies such as primary and secondary prevention should be reconsidered, especially in the most prevalent and unexpected increased regions, especially for those areas with the greatest proportions of their population over age 55. John Wiley and Sons Inc. 2021-06-09 /pmc/articles/PMC8290243/ /pubmed/34105887 http://dx.doi.org/10.1002/cam4.4046 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Zhang, Wei
Zeng, Wen
Jiang, Aofei
He, Zhi
Shen, Xiaoping
Dong, Xian
Feng, Jianglong
Lu, Hongguang
Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019
title Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019
title_full Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019
title_fullStr Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019
title_full_unstemmed Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019
title_short Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019
title_sort global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: an analysis of the global burden of disease study 2019
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290243/
https://www.ncbi.nlm.nih.gov/pubmed/34105887
http://dx.doi.org/10.1002/cam4.4046
work_keys_str_mv AT zhangwei globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT zengwen globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT jiangaofei globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT hezhi globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT shenxiaoping globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT dongxian globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT fengjianglong globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019
AT luhongguang globalregionalandnationalincidencemortalityanddisabilityadjustedlifeyearsofskincancersandtrendanalysisfrom1990to2019ananalysisoftheglobalburdenofdiseasestudy2019